BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18091699)

  • 1. Association between inflammatory markers and the interleukin-6 -174 G/C polymorphism is abolished in peripheral arterial occlusive disease.
    Potaczek DP; Undas A; Nowakowski T; Szczeklik A
    Int Angiol; 2007 Dec; 26(4):318-23. PubMed ID: 18091699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interleukin-1beta C+3953T gene polymorphism and peripheral arterial occlusive disease in Polish population].
    Potaczek DP; Krzanowski M; Sanak M
    Przegl Lek; 2005; 62(9):830-2. PubMed ID: 16541711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension.
    Wong LY; Leung RY; Ong KL; Cheung BM
    J Hum Hypertens; 2007 Nov; 21(11):875-82. PubMed ID: 17508011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-inflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia.
    Flex A; Gaetani E; Angelini F; Sabusco A; Chillà C; Straface G; Biscetti F; Pola P; Castellot JJ; Pola R
    J Intern Med; 2007 Jul; 262(1):124-30. PubMed ID: 17598820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.
    Libra M; Signorelli SS; Bevelacqua Y; Navolanic PM; Bevelacqua V; Polesel J; Talamini R; Stivala F; Mazzarino MC; Malaponte G
    J Clin Pathol; 2006 Feb; 59(2):211-5. PubMed ID: 16443741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men.
    Chiappelli M; Tampieri C; Tumini E; Porcellini E; Caldarera CM; Nanni S; Branzi A; Lio D; Caruso M; Hoffmann E; Caruso C; Licastro F
    Int J Immunogenet; 2005 Dec; 32(6):349-53. PubMed ID: 16313298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors.
    Orbe J; Beloqui O; Rodriguez JA; Belzunce MS; Roncal C; Páramo JA
    Clin Chim Acta; 2006 Jun; 368(1-2):138-43. PubMed ID: 16458279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the interleukin-6 c/g-174 polymorphism and circulating interleukin-6 on fibrinogen plasma levels.
    Margaglione M; Bossone A; Cappucci G; Colaizzo D; Grandone E; Di Minno G
    Haematologica; 2001 Feb; 86(2):199-204. PubMed ID: 11224491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single nucleotide polymorphism in the plasma PAF acetylhydrolase gene and risk of atherosclerosis in Japanese patients with peripheral artery occlusive disease.
    Unno N; Sakaguchi T; Nakamura T; Yamamoto N; Sugatani J; Miwa M; Konno H
    J Surg Res; 2006 Jul; 134(1):36-43. PubMed ID: 16650870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults.
    Kilpinen S; Hulkkonen J; Wang XY; Hurme M
    Eur Cytokine Netw; 2001 Mar; 12(1):62-8. PubMed ID: 11282548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort.
    Sekuri C; Cam FS; Sagcan A; Ercan E; Tengiz I; Alioglu E; Berdeli A
    Coron Artery Dis; 2007 Aug; 18(5):333-7. PubMed ID: 17627181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease.
    Smith FB; Connor JM; Lee AJ; Cooke A; Lowe GD; Rumley A; Fowkes FG
    Thromb Res; 2003; 112(4):209-16. PubMed ID: 14987913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
    Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
    J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6-174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients.
    Testa R; Olivieri F; Bonfigli AR; Sirolla C; Boemi M; Marchegiani F; Marra M; Cenerelli S; Antonicelli R; Dolci A; Paolisso G; Franceschi C
    Diabetes Res Clin Pract; 2006 Mar; 71(3):299-305. PubMed ID: 16140413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans.
    Koh SJ; Jang Y; Hyun YJ; Park JY; Song YD; Shin KK; Chae JS; Kim BK; Ordovas JM; Lee JH
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):238-44. PubMed ID: 18573122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of interleukin-6 gene and susceptibility to acute myocardial infarction.
    Vakili H; Ghaderian SM; Akbarzadeh Najar R; Tabatabaei Panah AS; Azargashb E
    Coron Artery Dis; 2011 Aug; 22(5):299-305. PubMed ID: 21512395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
    Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease.
    Flex A; Gaetani E; Pola R; Santoliquido A; Aloi F; Papaleo P; Dal Lago A; Pola E; Serricchio M; Tondi P; Pola P
    Eur J Vasc Endovasc Surg; 2002 Sep; 24(3):264-8. PubMed ID: 12217290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.